Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Brightling

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
The European Respiratory Journal|July 2, 2008
What can we learn about airway smooth muscle from the company it keeps?S Siddiqui, F Hollins, C E Brightling
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 3, 2009
Interleukin-13: prospects for new treatmentsC E Brightling, S Saha, F Hollins
Thorax|February 5, 2004
Prednisolone response in patients with COPDI D Pavord, R Siva, C E Brightling
The European Respiratory Journal|March 2, 2012
The RAGE against the stormL Di Candia, R Saunders, C E Brightling
Chronic Respiratory Disease|November 11, 2005
Improving the sampling technique of arterialized capillary samples to obtain more accurate PaO2 measurementsS Wimpress, D D Vara, C E Brightling
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 10, 2018
New and emerging drug treatments for severe asthmaS Diver, R J Russell, C E Brightling
Journal of Leukocyte Biology|May 1, 1993
Isoprenaline inhibits thromboxane B2 release from U937 cellsC E Brightling, A J Baker, R W Fuller
The European Respiratory Journal|December 7, 2007
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?S Siddiqui, F Hollins, S Saha, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 24, 2011
Lung damage and airway remodelling in severe asthmaC E Brightling, S Gupta, S Gonem, et al.
Current Opinion in Allergy and Clinical Immunology|June 15, 2011
Evidence for phenotype-driven treatment in asthmatic patientsSherif Gonem, Dhananjay Desai, Salman Siddiqui, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
The European Respiratory Journal|July 2, 2008
What can we learn about airway smooth muscle from the company it keeps?S Siddiqui, F Hollins, C E Brightling
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 3, 2009
Interleukin-13: prospects for new treatmentsC E Brightling, S Saha, F Hollins
Thorax|February 5, 2004
Prednisolone response in patients with COPDI D Pavord, R Siva, C E Brightling
The European Respiratory Journal|March 2, 2012
The RAGE against the stormL Di Candia, R Saunders, C E Brightling
Chronic Respiratory Disease|November 11, 2005
Improving the sampling technique of arterialized capillary samples to obtain more accurate PaO2 measurementsS Wimpress, D D Vara, C E Brightling
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 10, 2018
New and emerging drug treatments for severe asthmaS Diver, R J Russell, C E Brightling
Journal of Leukocyte Biology|May 1, 1993
Isoprenaline inhibits thromboxane B2 release from U937 cellsC E Brightling, A J Baker, R W Fuller
The European Respiratory Journal|December 7, 2007
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?S Siddiqui, F Hollins, S Saha, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 24, 2011
Lung damage and airway remodelling in severe asthmaC E Brightling, S Gupta, S Gonem, et al.
Current Opinion in Allergy and Clinical Immunology|June 15, 2011
Evidence for phenotype-driven treatment in asthmatic patientsSherif Gonem, Dhananjay Desai, Salman Siddiqui, et al.
Pageof 9